1. |
Eosinophils are just the tip of the iceberg for eosinophilic esophagitis |
Eric E. Low, Rena Yadlapati |
|
2. |
The first approved therapy in infants and young children with EoE – now the big question: where will dupilumab fit into real-world practice? |
Eric E. Low, Rena Yadlapati |
|
3. |
Immune checkpoint inhibitor induced colitis |
Anusha S. Thomas, Yang Lu, Mathew Campbell, John A. Thompson, Dongfeng Tan, David M. Faleck, Yinghong Wang |
|
4. |
Persistent severe abdominal pain in a 40-year-old male patient |
Shin Kashima, Yuki Kamikokura, Kentaro Moriichi |
|
5. |
Engineering therapeutic Tregs to overexpress GPR15 improves functional fitness for in vivo gut homing |
Tanja M. Müller, Li-Juan Liu, Manuel Wiesinger, TRR241 Working Group, Markus F. Neurath, Caroline J. Voskens, Sebastian Zundler |
|
6. |
Novel immune manipulators for IBD: miniproteins! |
Eytan Wine |
|
7. |
Early Life Exposure to Parental Crohn's disease is Associated with Offspring’s Gut Microbiome, Gut Permeability and Increased Risk of Future Crohn's Disease |
Sun-Ho Lee, Maham Bushra, Lanhui Qiu, Anne M. Griffiths, Williams Turpin, Kenneth Croitoru, Crohn’s Colitis Canada-GEM consortium |
|
8. |
The Educational Impact of the GI Hospitalist Model on Gastroenterology Fellowship Training |
Ryan Flanagan, Calley Levine, Kenneth Hung, Michelle Hughes, Cassandra D.L. Fritz, David Wan, Daniel J. Stein |
|
9. |
Safety and Tolerability of CP101, a full spectrum, oral microbiome therapeutic for the prevention of recurrent C. difficile infection: A Phase 2 Randomized Controlled Trial. |
Jessica R. Allegretti, Colleen R. Kelly, Thomas Louie, Monika Fischer, Susy Hota, Bharat Misra, Nick W. Van Hise, Eugene Yen, Jeffrey S. Bullock, Michael Silverman, Ian Davis, Sarah K. McGill, Darrell S. Pardi, Robert Orenstein, Ari Grinspan, Najwa El-Nachef, Paul Feuerstadt, Thomas J. Borody, Sahil Khanna S, Shrish Budree, Zain Kassam |
|
10. |
Use of Large Language Models to Identify Surveillance Colonoscopy Intervals – A Feasibility Study |
Vedant Acharya, Vignesh Kumaresan, Jonathan England, Shivan Mehta, Daniel Sussman, Amar Deshpande |
|
11. |
CME Exam 1: Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis |
|
|
12. |
CME Exam 2: Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis |
|
|
13. |
Interventions to Increase Follow-Up of Abnormal Stool-Based Colorectal Cancer Screening Tests in Safety Net Settings: A Systematic Review |
Rachel B. Issaka, Ari Bell-Brown, Teresa Jewell, Sara L. Jackson, Bryan J. Weiner |
|
14. |
Cover 1 |
|
|
15. |
Editorial Board |
|
|
16. |
Elsewhere in The AGA Journals (Preview Section) |
|
|
17. |
Table of Contents |
|
|
18. |
Corrigendum |
|
|
19. |
Hidden Footprints in Ascites: Lessons from a Mystery Enduring for 200 Years |
Yoichi Nakatsu, Makoto Furihata, Taro Osada |
|
20. |
A brain-gut pathway for stress-induced microbiome changes |
Sarah A. Najjar, Kara Gross Margolis |
|
21. |
Multimodal profiling of peripheral blood identifies proliferating circulating effector CD4+ T cells as predictors for response to integrin α4β7-blocking therapy in inflammatory bowel disease |
Veronika Horn, Camila A. Cancino, Lisa Maria Steinheuer, Benedikt Obermayer, Konstantin Fritz, Anke L. Nguyen, Kim Susan Juhran, Christina Plattner, Diana Bösel, Lotte Oldenburg, Marie Burns, Axel Ronald Schulz, Mariia Saliutina, Eleni Mantzivi, Donata Lissner, Thomas Conrad, Mir-Farzin Mashreghi, Sebastian Zundler, Elena Sonnenberg, Michael Schumann, Lea-Maxie Haag, Dieter Beule, Lukas Flatz, TRR241 IBDome Consortium, Zlatko Trjanoski, Geert D’Haens, Carl Weidinger, Henrik E. Mei, Britta Siegmund, Kevin Thurley, Ahmed N. Hegazy |
|
22. |
Surveillance for hepatocellular carcinoma in cirrhosis: End of monopoly for serum alpha fetoprotein |
Lung-Yi Mak, Man-Fung Yuen |
|
23. |
It Runs in the Family: What Studying Unaffected Individuals in Simplex and Multiplex Families Tells Us About IBD Development |
Jonas J. Rudbaek, Aleksejs Sazonovs, Tine Jess |
|
24. |
The Impact of Population-Based Helicobacter pylori Test-To-Treat Strategies on Gastric Cancer Outcomes |
Corey J. Ketchem |
|
25. |
Methodological Aspects of "Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention: A Randomized Placebo-Controlled Trial" |
Manjeet Kumar Goyal, Karan Sachdeva, Omesh Goyal |
|
26. |
Evaluating Research Strategy and Inclusion Criteria of Long-term Proton Pump Inhibitor Use |
Yanqing Niu, Xiaherezhati Aihaiti, Man Li |
|
27. |
Reply |
Hanseul Kim, Long H. Nguyen |
|
28. |
Reply to Iovino et al, Goyal et al, Zhu, Guo et al, and Tian et al |
Fernando Azpiroz |
|
29. |
Interventions for Improving Quality of Colonoscopy |
Qing-Hua Wang, Min Zhang, Hua Chen, Wei Han |
|
30. |
Advancing Biofeedback Therapy in Abdominal Distention: Recommendations for Methodological Improvements and Increased Generalizability |
Xiaolong Guo, Yongfeng Wang, Yuan Yuan |
|
31. |
Refining Biofeedback in Gastroenterology: Enhancing Precision in Thoracoabdominal Motion Studies |
Junkun Zhu |
|
32. |
Focus on Psychological Intervention: Insights from Thoracoabdominal Wall Motion–Guided Biofeedback Treatment of Abdominal Distention |
Chenhong Tian, Changlin Zhai, Haihua Pan |
|
33. |
Reply |
Anna-Klara Wiklund, Giola Santoni, Jesper Lagergren |
|
34. |
Helicobacter pylori Eradication Treatment Might Help Reduce the Risk of Esophageal Adenocarcinoma |
Hui Chen, Chuanli Ren |
|
35. |
Enhancing Research on Helicobacter pylori Eradication and Esophageal Adenocarcinoma Risk: A Call for Broader Studies and Methodological Rigor |
Xiaolong Guo, Yongfeng Wang, Hui Cai |
|
36. |
Detection of Gastrointestinal Bleeding with Large Language Models to Aid Quality Improvement and Appropriate Reimbursement |
Neil S. Zheng, Vipina K. Keloth, Kisung You, Daniel Kats, Darrick K. Li, Ohm Deshpande, Hamita Sachar, Hua Xu, Loren Laine, Dennis L. Shung |
|
37. |
Obesity facilitated colon cancer progression is mediated by increased diacylglycerol o-acyltransferases 1 and 2 (DGAT1/2) levels |
Jenisha Ghimire, Morgan E. Collins, Patricia Snarski, Angelle N. King, Emmanuelle Ruiz, Rida Iftikhar, Harrison M. Penrose, Krzysztof Moroz, Tyler Rorison, Melody Baddoo, Muhammad Anas Naeem, Arnold H. Zea, Scott T. Magness, Erik F. Flemington, Susan E. Crawford, Suzana D. Savkovic |
|
38. |
Myosin Vb Traffics P-glycoprotein to the Apical Membrane of Intestinal Epithelial Cells |
Sarah A. Dooley, Elena Kolobova, Andreanna Burman, Izumi Kaji, Jessica R. Digrazia, Rachel Stubler, Anna Goldstein, Charulekha Packirisamy, Alexander W. Coutts, Milena Saqui-Salces, Nan Gao, Melinda A. Engevik, Mitchell D. Shub, James R. Goldenring, Amy C. Engevik |
|
39. |
A Phase 3 Biomarker Validation of GALAD for the Detection of Hepatocellular Carcinoma in Cirrhosis |
Tracey L. Marsh, Neehar D. Parikh, Lewis R. Roberts, Myron E. Schwartz, Mindie H. Nguyen, Alex Befeler, Stephanie Page-Lester, Nabihah Tayob, Sudhir Srivastava, Jo Ann Rinaudo, Amit G. Singal, K. Rajender Reddy, Jorge A. Marrero |
|
40. |
The Brain and the Immune System: A Dynamic Duo in Detecting and Defending |
Lin Y. Hung, Kara Gross Margolis |
|
41. |
Comments on “Diagnosis and Management of Pancreatic Cysts” |
Santhi Swaroop Vege |
|
42. |
Reply |
Timothy B. Gardner, Walter G. Park, Peter J. Allen |
|
43. |
Dual Targeting of Syndecan-1 and Glucose Transporter-1 With a Novel Lipid-Based Delivery System Enhances Therapeutic Efficacy and Overcomes Chemoresistance in Pancreatic Ductal Adenocarcinoma |
Hari Krishna Rachamala, Naga Malleswara Rao Nakka, Ramcharan Singh Angom, Santanu Bhattacharya, Krishnendu Pal, Debabrata Mukhopadhyay |
|
44. |
Reevaluating stemness in the intestinal crypt |
Samuel Asfaha, Nicola L. Jones |
|
45. |
Stress Ulcer Prophylaxis in the Intensive Care Unit – More Evidence of Benefit |
Rishad Khan |
|
46. |
EUS-guided Rendezvous versus Needle-knife Sphincterotomy Following Difficult Biliary Cannulation in ERCP for Benign Disease |
Nauzer Forbes |
|
47. |
Where do non-invasive colorectal cancer tools ‘FIT’ alongside colonoscopy in the surveillance of high-risk patients? |
Kevin J. Monahan |
|
48. |
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review |
Amit Patel, Loren Laine, Paul Moayyedi, Justin Wu |
|
49. |
Portal Fibrosis and the Ductular Reaction: Pathophysiological Role in the Progression of Liver Disease and Translational Opportunities |
Vikas Gupta, Tejasav S. Sehrawat, Massimo Pinzani, Mario Strazzabosco |
|
50. |
A Head-to Head Comparison of Risankizumab and Ustekinumab as Second-Line Therapy in Moderate to Severely Active Crohn’s Disease |
Pavel S. Roshanov, Reena Khanna |
|
51. |
Reply |
Ali Rezaie, Yee Hui Yeo |
|
52. |
Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis |
Pavel S. Roshanov, Reena Khanna |
|
53. |
Proteomic Biomarkers in Serum Predict Villous Atrophy Development in Asymptomatic Potential Celiac Disease Children at Time of Diagnosis |
Renata Auricchio, Roberta Mandile, Janneke Samsom, Chiara Esposito, Rossella de Cegli, Luigi Greco, European Laboratory for Food Induced Disease (ELFID) Group |
|
54. |
Pragmatic Resect and Discard Implementation Using Computer-Assisted Optical Polyp Diagnosis |
Mahsa Taghiakbari, Douglas K. Rex, Heiko Pohl, Roupen Djinbachian, Felix Huang, Cesare Hassan, Daniel Von Renteln |
|
55. |
Reply |
Laurens A. Van Kleef, Willem Pieter Brouwer |
|
56. |
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Adverse Anesthesia Events: Caution Warranted When Interpreting Associations With Pulmonary Aspiration |
Inuk Zandvakili, Wei-Wen Hsu, Gregory G. Ginsberg |
|
57. |
Comments on “Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction” |
Yuting Guan, Jiaming Yang, Zudong Xu |
|
58. |
With Great Statistical Power Comes Great Responsibility: Pitfalls of Claims Database Research on the Periprocedural GLP-1 Receptor Agonist Management Debate |
Brent Hiramoto, Thomas R. Mccarty, Mayssan Muftah, Walter W. Chan |
|
59. |
Tofu-like Disfiguring Colitis |
Nie Kai, Zhao Lian, Wang Xiaoyan |
|
60. |
Healthy First-Degree Relatives From Multiplex Families vs Simplex Families Have a Higher Subclinical Intestinal Inflammation, a Distinct Fecal Microbial Signature, and Harbor a Higher Risk of Developing Crohn’s Disease |
Pablo A. Olivera, Helena Martinez-Lozano, Haim Leibovitzh, Mingyue Xue, Anna Neustaeter, Osvaldo Espin-Garcia, Wei Xu, Karen L. Madsen, David S. Guttman, Charles N. Bernstein, Baruch Yerushalmi, Jeffrey S. Hyams, Maria T. Abreu, John K. Marshall, Iwona Wrobel, David R. Mack, Kevan Jacobson, Alain Bitton, Guy Aumais, Remo Panacionne, Levinus A. Dieleman, Mark S. Silverberg, A. Hillary Steinhart, Paul Moayyedi, Dan Turner, Anne M. Griffiths, Williams Turpin, Sun-Ho Lee, Kenneth Croitoru, Crohn’s and Colitis Canada (CCC) Genetic, Environmental, Microbial (GEM) Project Research Consortium |
|
61. |
Intestinal Permeability in Disorders of Gut-Brain Interaction: From Bench to Bedside |
Madhusudan Grover, Tim Vanuytsel, Lin Chang |
|
62. |
Unveiling Cancer-Related Metaplastic Cells in Both Helicobacter pylori Infection and Autoimmune Gastritis |
Stella G. Hoft, Michelle Brennan, Javier A. Carrero, Nicholas M. Jackson, Challen A. Pretorius, Tarin M. Bigley, José B. Sáenz, Richard J. DiPaolo |
|
63. |
Management of Small Bowel Crohn’s Disease Strictures: To Cut, to Stretch, or to Treat Inflammation? |
Cathy Lu, Brian G. Feagan, Joel G. Fletcher, Mark Baker, Stefan Holubar, Florian Rieder, Stenosis Therapy and Anti-Fibrosis Research Consortium |
|
64. |
Stool-Based Testing for Post-Polypectomy Colorectal Cancer Surveillance Safely Reduces Colonoscopies: The Molecular Stool Testing for Colorectal Cancer Surveillance Study |
Beatriz Carvalho, Willemijn de Klaver, Francine van Wifferen, Meta C.J. van Lanschot, Alouisa J.P. van Wetering, Quirine E.W. van der Zander, Margriet Lemmens, Anne S. Bolijn, Marianne Tijssen, Pien Delis-van Diemen, Nikkie Buekers, Kathleen Daenen, Jaleesa van der Meer, Pauline G. van Mulligen, Brenda S. Hijmans, Sander de Ridder, Lana Meiqari, Mariska Bierkens, René W.M. van der Hulst, Johan P.H. Kuyvenhoven, Annemarie M. van Berkel, Annekatrien C.T.M. Depla, Monique E. van Leerdam, Jeroen M. Jansen, Caroline A. Wientjes, Jan-Willem A. Straathof, Eric T.P. Keulen, Dewkoemar Ramsoekh, Leon M.G. Moons, Michael Zacherl, Ad A.M. Masclee, Meike de Wit, Marjolein J.E. Greuter, Manon van Engeland, Evelien Dekker, Veerle M.H. Coupé, Gerrit A. Meijer |
|
65. |
Pancreatic Cancer–Induced Metabolic Dysregulation Syndrome: Clinical Profile, Proposed Mechanisms, and Unanswered Questions |
Lanisha Patterson, Frederico G.S. Toledo, Anirban Maitra, Suresh T. Chari |
|
66. |
Reply |
Roupen Djinbachian, Douglas K. Rex, Daniel Von Renteln |
|
67. |
Reply |
Zainab Aziz, Sheila Rustgi, Chin Hur |
|
68. |
Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare and Medicaid Services Coverage Decision |
Amar K. Das, Craig Eagle, Amirali Talasaz |
|
69. |
Corrigendum |
|
|
70. |
Limitations in Autonomous Artificial Intelligence Optical Diagnosis |
Qi Mei, Poi Kuo, James Cheng-Chung Wei |
|
71. |
A Rare Cause of liver injury in an adult |
Zixing Dai, Yuwen Li, Chuanlong Zhu |
|
72. |
Reply |
Rosita Van Den Puttelaar, Pedro Nascimento De Lima, Iris Lansdorp-Vogelaar |
|
73. |
Reply |
Uri Ladabaum, Ajitha Mannalithara, Robert E. Schoen, Jason A. Dominitz, David Lieberman |
|
74. |
A Comparative Review of Autonomous Artificial Intelligence versus Artificial Intelligence–Assisted Human Optical Diagnosis of Colorectal Polyps |
Tiantian Cao, Chengqian Zhong |
|
75. |
Combining Colonoscopy With Fecal Immunochemical Test Can Improve Current Familial Colorectal Cancer Colonoscopy Surveillance: A Modelling Study |
Francine Van Wifferen, Marjolein J.E. Greuter, Monique E. van Leerdam, Marcel B.W. Spanier, Evelien Dekker, Hans F.A. Vasen, Iris Lansdorp-Vogelaar, Karen Canfell, Gerrit A. Meijer, Tanya M. Bisseling, Nicoline Hoogerbrugge, Veerle M.H. Coupé |
|
76. |
Development and Validation of an Integrative Risk Score for Future Risk of Crohn’s Disease in Healthy First-Degree Relatives: A Multicentre Prospective Cohort Study |
Sun-Ho Lee, Williams Turpin, Osvaldo Espin-Garcia, Wei Xu, Kenneth Croitoru, Crohn’s Colitis Canada-Genetic, Environmental, Microbial Project Research Consortium |
|
77. |
Reply |
Roupen Djinbachian, Douglas K. Rex, Daniel Von Renteln |
|
78. |
Corrigendum |
|
|
79. |
Recompensation of Chronic Hepatitis C–Related Decompensated Cirrhosis Following Direct-Acting Antiviral Therapy: Prospective Cohort Study From a Hepatitis C Virus Elimination Program |
Madhumita Premkumar, Radha K. Dhiman, Ajay Duseja, Rohit Mehtani, Sunil Taneja, Ekta Gupta, Pankaj Gupta, Anchal Sandhu, Prerna Sharma, Sahaj Rathi, Nipun Verma, Anand V. Kulkarni, Harish Bhujade, Sreedhara B. Chaluvashetty, Naveen Kalra, Gagandeep S. Grover, Jasvinder Nain, K. Rajender Reddy |
|
80. |
Exon-Skipping–Based Subtyping of Colorectal Cancers |
Aslihan Ambeskovic, Matthew N. McCall, Jonathan Woodsmith, Hartmut Juhl, Hartmut Land |
|
81. |
Glutamine Supplementation as a Novel Metabolic Therapeutic Strategy for LIG3-Dependent Chronic Intestinal Pseudo-obstruction |
Chiara Diquigiovanni, Nicola Rizzardi, Erica Cataldi-Stagetti, Livia Gozzellino, Federica Isidori, Francesca Valenti, Arianna Orsini, Annalisa Astolfi, Tania Giangregorio, Loris Pironi, Elisa Boschetti, Serena Arrigo, Alessandra Maresca, Penelope Magnoni, Anna Costanzini, Valerio Carelli, Mariko Taniguchi-Ikeda, Romana Fato, Christian Bergamini, Roberto De Giorgio, Elena Bonora |
|
82. |
Crohn’s Patients and Healthy Infants Share Immunodominant B Cell Response to Commensal Flagellin Peptide Epitopes |
Qing Zhao, Lennard Wayne Duck, John T. Killian, Alexander F. Rosenberg, Peter J. Mannon, R. Glenn King, Lee A. Denson, Subra Kugathasan, Edward N. Janoff, Maria C. Jenmalm, Charles O. Elson |
|
83. |
Unanticipated Findings With Upadacitinib Therapy |
Taylor A. Karl, McKinzie Johnson, Frank I. Scott |
|
84. |
Gut Barrier Leakiness: Time to Take It Seriously? |
Javier Santos, Maria Rescigno |
|
85. |
Dietary Pattern Linking to Intestinal Microbial Characteristics and Colorectal Cancer Risk |
Jun Sun |
|
86. |
Endoscopic Gastric Fundal Mucosal Ablation Induces Weight Loss in Adults With Obesity |
Daniel B. Maselli, Lauren L. Donnangelo, Chase Wooley, Christopher Chapman, Vivek Kumbhari, Christopher E. Mcgowan |
|
87. |
Effect of Enterotype-Dependent Stability of the Gut Microbiome on Postgastrectomy Malnutrition in Gastric Cancer Patients |
Han Na Oh, Woo Jun Sul, Sang-Yong Son, Sang-Uk Han, Hoon Hur, Sun Gyo Lim |
|
88. |
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases |
Joseph J. Zhao, Chin-Ann Johnny Ong, Supriya Srivatsava, Daryl Kai Ann Chia, Haoran Ma, Kiekyon Huang, Taotao Sheng, Kalpana Ramnarayanan, Xuewen Ong, Su Ting Tay, Takeshi Hagihara, Angie Lay Keng Tan, Melissa Ching Ching Teo, Qiu Xuan Tan, Gillian Ng, Joey Wee-Shan Tan, Matthew Chau Hsien Ng, Yong Xiang Gwee, Robert Walsh, Jia Hao Law, Asim Shabbir, Guowei Kim, Yvonne Tay, Zhisheng Her, Giuseppe Leoncini, Bin Tean The, Jing Han Hong, Ryan Yong Kiat Tay, Chong Boon Teo, Mark P.G. Dings, Maarten Bijlsma, Jeffrey Huey Yew Lum, Sachin Mathur, Filippo Pietrantonio, Steven M. Blum, Hanneke van Laarhoven, Samuel J. Klempner, Wei Peng Yong, Jimmy Bok Yan So, Qingfeng Chen, Patrick Tan, Raghav Sundar |
|
89. |
AGA Clinical Practice Update on Pregnancy-Related Gastrointestinal and Liver Disease: Expert Review |
Shivangi Kothari, Yalda Afshar, Lawrence S. Friedman, Joseph Ahn |
|
90. |
Gluten-Dependent Activation of CD4+ T Cells by MHC Class II–Expressing Epithelium |
Sara Rahmani, Heather J. Galipeau, Alexandra V. Clarizio, Xuanyu Wang, Amber Hann, Gaston H. Rueda, Utkarshini N. Kirtikar, Marco Constante, Mark Wulczynski, Hsuan-Ming Su, Rebecca Burchett, Jonathan L. Bramson, Maria Ines Pinto-Sanchez, Juan Pablo Stefanolo, Sonia Niveloni, Michael G. Surette, Joseph A. Murray, Robert P. Anderson, Premysl Bercik, Alberto Caminero, Fernando G. Chirdo, Tohid F. Didar, Elena F. Verdu |
|
91. |
Expanding the Diagnostic Toolkit in Chronic Cholestasis |
Nicholas Smith, Jennifer Borowsky, James A. Thomas |
|
92. |
Development and Implementation of a Clinical Decision Support Tool to Improve Adherence to Colonoscopy Follow-Up Guidelines |
Brian A. Sullivan, Hochong Gilles, Lyndsey Knauf, Steve S. Choi, Jill Moore, Jason A. Dominitz |
|
93. |
A Concerning Case of Severe Gastritis With Gastrointestinal Protein Loss |
Xinyu Liu, Hao Tang, Bei Tan |
|
94. |
An Empirical Dietary Pattern Associated with the Gut Microbial Features in Relation to Colorectal Cancer Risk |
Kai Wang, Chun-Han Lo, Raaj S. Mehta, Long H. Nguyen, Yiqing Wang, Wenjie Ma, Tomotaka Ugai, Hidetaka Kawamura, Satoko Ugai, Yasutoshi Takashima, Kosuke Mima, Kota Arima, Kazuo Okadome, Marios Giannakis, Cynthia L. Sears, Jeffrey A. Meyerhardt, Kimmie Ng, Nicola Segata, Jacques Izard, Eric B. Rimm, Wendy S. Garrett, Curtis Huttenhower, Edward L. Giovannucci, Andrew T. Chan, Shuji Ogino, Mingyang Song |
|
95. |
High Pathological Response Rate After Neoadjuvant Immunotherapy in Locally Advanced Mismatch Repair-Deficient Colon Cancer (NICHE-2 Study) |
Ville Sallinen |
|
96. |
Reply |
Natalie Wilson, Mohammad Bilal, Aasma Shaukat |
|
97. |
A MERFISHing Expedition for Colitis |
Jay R. Thiagarajah |
|
98. |
Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response |
Xiangdong Cheng, Enyu Dai, Jibo Wu, Natasha M. Flores, Yanshuo Chu, Ruiping Wang, Minghao Dang, Zhiyuan Xu, Guangchun Han, Yunhe Liu, Deyali Chatterjee, Can Hu, Jieer Ying, Yian Du, Litao Yang, Xiaoqing Guan, Shaowei Mo, Xuanye Cao, Guangsheng Pei, Jiahui Jiang, Xiaoyin Lu, Ana Morales Benitez, Rebecca E. Waters, Melissa Pool Pizzi, Namita Shanbhag, Yibo Fan, Fuduan Peng, Samir M. Hanash, George Calin, Andrew Futreal, Shumei Song, Cassian Yee, Pawel K. Mazur, Jiang-Jiang Qin, Jaffer A. Ajani, Linghua Wang |
|
99. |
The Evolving Story of Blastocystis: From Foe to Friend |
Daniel Keszthelyi |
|
100. |
Tofacitinib Uptake by Patient-Derived Intestinal Organoids Predicts Individual Clinical Responsiveness |
Kyung Ku Jang, David Hudesman, Drew R. Jones, P’ng Loke, Jordan E. Axelrad, Ken Cadwell, Tofacitinib Working Group |
|